The Belgian pharmaceutical industry has raised concerns around pressures being applied to the national healthcare budget for innovative medicines. 30 January 2023
Research from the IQVIA Institute for Human Data Science shows that total spending and global demand for medicines could hit $1.9 trillion by 2027. 27 January 2023
In the context of a sagging economy and a multitude of economic woes, lawmakers in the UK may be receptive to news of the potential for medicines manufacturing 24 January 2023
Since 2019, in the Latin American pharma market, imports have doubled the number of exports, writes The Pharma Letter's local correspondent. 20 January 2023
There is no shortage of criticism currently being directed at the UK government from the public sector, especially where healthcare is concerned. 18 January 2023
In the USA, the National Institute of Allergy and Infectious Diseases (NIAID) has awarded $5.5 million to the Blumberg Institute to research treatments for yell 18 January 2023
The trade group representing the UK pharmaceutical industry has published a report highlighting significant variation in access to innovative medicines in the c 17 January 2023
Large pharmaceutical firms are increasingly upset at the deal they agreed with the British government on drug pricing, the Voluntary Scheme for Branded Medicine 16 January 2023
One of the pioneers of mRNA technologies, BioNTec, is investing the proceeds of its work during the pandemic on its original focus - cancer vaccines. 6 January 2023
Never has the importance of Flanders’ biopharmaceutical output to the international community been more obvious than it was during the COVID-19 crisis. 3 January 2023
Faith in the transparency of the US regulatory process has been shaken, following an accusatory report from influential congressional committees into the approv 30 December 2022
A commercial stage biopharmaceutical R&D company, focused on the development of products that address the medical challenges in the therapeutic area of anti-infectives.